BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3474067)

  • 1. Origins of macrophage diversity: functional and phenotypic analysis of cloned populations of mouse splenic macrophages.
    Walker WS
    Cell Immunol; 1987 Jul; 107(2):417-32. PubMed ID: 3474067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antigen presentation by cloned populations of mouse splenic macrophages.
    Walker WS
    J Immunol; 1989 Oct; 143(7):2142-5. PubMed ID: 2778319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes.
    Roberson SM; Walker WS
    Cell Immunol; 1988 Oct; 116(2):341-51. PubMed ID: 2460250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
    Sikorski EE; Burns LA; McCoy KL; Stern M; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):143-56. PubMed ID: 1714636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ia antigen in colonies of bone-marrow-derived macrophages.
    Yen SE; Beelen RH; Walker WS
    J Leukoc Biol; 1987 Dec; 42(6):697-703. PubMed ID: 3500256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive antigen presentation by mouse splenic macrophages is restricted to the progeny of a distinct progenitor population.
    Walker WS; Sun D
    Cell Immunol; 1991 Apr; 133(2):342-51. PubMed ID: 1901768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth.
    Yurochko AD; Burger CJ; Elgert KD
    Cytometry; 1990; 11(6):725-35. PubMed ID: 2200657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth.
    Garner RE; Malick AP; Elgert KD
    J Leukoc Biol; 1986 Nov; 40(5):561-74. PubMed ID: 3464674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic capacity of macrophage hybridomas.
    Tzehoval E; Dagan S; Eisenbach L; Atsmon J; Feldman M
    Eur J Immunol; 1989 Jan; 19(1):89-96. PubMed ID: 2465907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-hybridomas: generation, structure, and function.
    Tzehoval E; Segal S; Zinberg N; Feldman M
    J Immunol; 1984 Apr; 132(4):1741-7. PubMed ID: 6607946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of cloned macrophage hybridomas. V. Induction of suppressor T cell responses.
    Kawasaki H; Martin CA; Uchida T; Usui M; Noma T; Minami M; Dorf ME
    J Immunol; 1986 Oct; 137(7):2145-51. PubMed ID: 2944950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in macrophage populations: phenotypic differences between normal and tumor-bearing host macrophages.
    Yurochko AD; Pyle RH; Elgert KD
    Immunobiology; 1989 Feb; 178(4-5):416-35. PubMed ID: 2654009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type.
    DeKruyff RH; Fang Y; Umetsu DT
    J Immunol; 1992 Dec; 149(11):3468-76. PubMed ID: 1358971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
    Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
    J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immortalization of growth factor-dependent mouse splenic macrophages derived from cloned progenitors.
    Wilson CM; Gatewood JW; McCormack JM; Walker WS
    J Immunol Methods; 1991 Mar; 137(1):17-25. PubMed ID: 1707081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of helper-T-cell proliferation by recognition of Ia and Mac-1 antigens on phagocytic cells of the thymic reticulum.
    Papiernik M; el Rouby S
    Cell Immunol; 1988 Apr; 113(1):95-106. PubMed ID: 2966683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA; Wahl LM; Vogel SN
    J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of benzo(a)pyrene-induced modulation of antigen presentation.
    Myers MJ; Schook LB; Bick PH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):399-404. PubMed ID: 3497259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine macrophage cell line AP284 presents antigen to cloned MT4+, Lyt-2- T cells in vitro and in vivo.
    Klasen IS; de Jong JP; Voerman JS; Ladestein RM; Leenen PJ; Benner R
    Immunobiology; 1988 Dec; 178(3):261-74. PubMed ID: 2906628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.